LinkedIn Profile

Access Five Prime Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:fprx 31220 May 5th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology May 5th, 2021 08:48AM May 5th, 2021 08:48AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 May 4th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology May 4th, 2021 08:41AM May 4th, 2021 08:41AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 May 3rd, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology May 2nd, 2021 11:41PM May 2nd, 2021 11:41PM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 May 2nd, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology May 2nd, 2021 10:14AM May 2nd, 2021 10:14AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 May 1st, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology Apr 30th, 2021 10:33PM May 1st, 2021 02:04PM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 Apr 30th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology Apr 30th, 2021 09:07AM Apr 30th, 2021 09:07AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 Apr 29th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 95.00 Open Biotechnology Apr 28th, 2021 10:34PM Apr 29th, 2021 08:51AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 Apr 28th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 98.00 Open Biotechnology Apr 28th, 2021 08:48AM Apr 28th, 2021 08:48AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 Apr 27th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 98.00 Open Biotechnology Apr 26th, 2021 10:32PM Apr 27th, 2021 08:39AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:fprx 31220 Apr 26th, 2021 12:00AM Five Prime Therapeutics, Inc. 7.7K 98.00 Open Biotechnology Apr 26th, 2021 08:22AM Apr 26th, 2021 08:22AM Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us, and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com. Open Open 111 Oyster Point Boulevard South San Francisco CA US 94080 Five Prime Therapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.